文献速递心力衰竭与心肌病高血压

心肌病基因突变与子痫前期的关联研究

Cardiomyopathy and Preeclampsia.
PubMed 文献 · Circulation · 2018-01-01

研究对181例子痫前期患者进行全外显子测序,检测43个心肌病相关基因的罕见变异,并与530例局部对照及Exome Aggregation Consortium数据比较。

要点

  • 子痫前期患者心肌病基因功能缺失变异患病率显著高于局部对照(5.5% vs 2.5%,P=0.014)。

核心结论

  • 发生子痫前期的女性更可能携带心肌病相关基因的蛋白改变突变,尤其是TTN基因。

研究设计与样本

  • 子痫前期登记与生物样本库参与者,有子痫前期病史者完成问卷并提供医疗记录确认诊断,采集唾液DNA行全外显子测序。
  • 检测43个心肌病相关基因中罕见变异(次要等位基因频率<0.1%),错义变异经7种标准功能预测算法中任一判定为损伤性则认定为损伤性错义,导致终止获得、剪接或移码插入缺失的变异定义为功能缺失。

主要发现

  • 在43个心肌病基因中检测到10个罕见功能缺失变异和228个罕见损伤性错义变异。
  • 子痫前期组功能缺失变异患病率为5.5%,显著高于局部对照的2.5%(P=0.014)。

关键数值与推荐

  • 罕见变异定义为次要等位基因频率<0.1%。
  • 损伤性错义变异定义为7种标准功能预测算法中任一判定为损伤性。
  • 功能缺失变异定义为导致终止获得、剪接或移码插入缺失的变异。

临床怎么用

  • 对子痫前期女性检测心肌病相关基因变异(尤其TTN)可能有助于更特异的诊断、分类、咨询和管理。

局限性

  • 子痫前期患者96%为白人,结果外推需谨慎。
  • 对照组未排除子痫前期,可能低估组间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is associated with diastolic dysfunction, peripartum cardiomyopathy, and both pre-existing and subsequent maternal cardiovascular disease. Gene mutations causing idiopathic cardiomyopathy were recently implicated in peripartum cardiomyopathy. We sought to determine whether cardiomyopathy gene mutations are also a contributory factor in preeclampsia. METHODS: Subjects were participants in The Preeclampsia Registry and Biobank. After providing informed consent, subjects with a history of preeclampsia completed a detailed questionnaire and provided medical records for diagnostic confirmation. Saliva samples were collected for DNA isolation. Whole exome sequencing was performed to detect rare variants (minor allele frequency of <0.1%) in 43 genes associated with cardiomyopathy. Missense variants were deemed damaging missense if so classified by any of 7 standard function prediction algorithms. Variants were defined as loss-of-function if they caused a stop-gain, splicing, or frame-shift insertion or deletion. Results were compared with data from 2 control groups: unrelated women with a gynecologic disorder sequenced using the same methods and instruments (n=530) as well as published variant data from 33 000 subjects in the Exome Aggregation Consortium. Preeclampsia was not excluded in control groups. RESULTS: Of 181 subjects with confirmed preeclampsia, 96% were white. Seventy-two percent had ≥1 preterm preeclampsia delivery <37 weeks. Among preeclampsia subjects, whole exome sequencing demonstrated 10 rare loss-of-function variants and 228 rare damaging missense variants in the 43 cardiomyopathy genes considered. The prevalence of these loss-of-function variants was significantly higher in preeclampsia subjects (5.5%) compared with the local control (2.5%) population ( P=0.014). Sixty-eight percent of women with preeclampsia carried ≥1 loss-of-function or damaging missense variant (mean of 1.94 mutations). As seen with peripartum cardiomyopathy, most mutations (55%) were found in the TTN gene. Seventy-three percent of preeclampsia subjects had TTN mutations in the preeclampsia cohort versus 48% in local controls ( P=1.36E-11). DISCUSSION: Women who develop preeclampsia are more likely to carry protein-altering mutations in genes associated with cardiomyopathy, particularly in TTN. Mutations promoting cardiomyopathy are prevalent in preeclampsia, idiopathic cardiomyopathy, and peripartum cardiomyopathy, and they are important risk factors for a widening spectrum of cardiovascular disorders. Detecting these variants should allow more specific diagnosis, classification, counseling, and management of women at risk.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Gammill HS, Chettier R, Brewer A, et al. Cardiomyopathy and Preeclampsia. Circulation. 2018. PMID: 30021846. doi:10.1161/CIRCULATIONAHA.117.031527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。